About Us
Introduction
Print | Close | Text Size:A A A

 

Founded in 2003, Beijing Institute of Genomics (BIG), Chinese Academy of Sciences (CAS) is located in the Olympic Science and Technology Park since 2013. The current director is Professor XUE Yongbiao.

 

Since its establishment, BIG has accomplished several major research projects with remarkable success, especially the Chinese Superhybrid Rice Genome Project. The institute also actively participated in the Human Genome Project (HGP) and HapMap Project. Currently, BIG is leading several prestigious national research programs such as “polygenic mechanisms of microevolution” and “the CAS Precision Medicine Initiative”. In the past several years, BIG has achieved a series of major breakthroughs in the field of tumor microevolution, epigenetic inheritance, and precision genomics.

 

BIG has also developed many gene analysis tools with proprietary intellectual property rights significantly improved the bioinformatic computing capability, and developed new computation theory, software, algorithms, and data storage methods. Up till now, more than 800 articles have been published in SCI-indexed journals, including high-profile journals like Nature, Science, Cell and Nature Genetics.

 

To meet the national strategic demand of China on population health and sustainable development, as well as the forefront of life sciences, BIG puts its primary focus on the study of genomic structure, variation, functioning, and evolution; boosts the integration among genomics and other relevant subjects; and develops new theories, technologies, and methodologies of the genomics, aiming to establish BIG as one of the top centers for genomics study in the world.

 

BIG has established “CAS Key Laboratory of Genome Sciences & Information”, “CAS Key Laboratory of Genomic and Precision Medicine”, and “Big Data Center” (BIGD), as well as a state-of-the-art Core Genomic Facility, which helps perfect the scientific layout and organizational management of BIG to fulfill its goal.

 

Targeting the research fronts of genomics, CAS Key Laboratory of Genome Sciences & Information focuses on the establishment of new theories and the development of new technologies and methodologies of the genomics by taking full advantage of integrating various kinds of omics research. CAS Key Laboratory of Genomic and Precision Medicine focuses on the integration of population genetics and evolution theory to deal with cancer and other complex diseases in Chinese populations, aiming to facilitate the individualized treatment for health and wellness. Big Data Center serves to construct databases of big data integration and value-added curation to aid share and translation of big data in the support of activities in both academia and industry, with a primary focus on data on precision medicine and important bio resources.

 

From the end of Year 2015, BIG is leading the project of “the Precision Medicine Research in Chinese Population”, supported by CAS. The program aims to answer the challenges in the precision medicine of complex diseases among Chinese, which involves team work of multiple institutions. This program will lay foundations for the research system of precision medicine in China, as well as future development of BIG.

 

Other than research activities, BIG also pays attention to the translation of the scientific discoveries. For example, “Weiming-BIG joint Gene Research Institute” was launched cooperatively by BIG, the Hefei municipal government, and Beijing Sinobioway Group Co., to merge the basic research, industrial transformation, and clinical application. Moreover, “Collaborative Innovation Center for Forensic Genomics” has been set up by BIG and the Forensic Identification Center of the Ministry of Public Security to facilitate the application of forensic genomics technology. The efforts in setting up industrialization bases and clinical application centers help promote the clinical or industry applications of precision medical, molecule detection techniques, and big data.

 

BIG is targeting the key questions of genomics science, focus on the national demand and the future development of BIG. With high starting point and standard, we will establish one world’s leading research center to achieve major breakthroughs and significant theoretical innovations.